Interferon (IFN)-inducible protein 16 (IFI16) regulates human immunodeficiency virus replication by inducing innate immune responses as a DNA sensor. Human T-lymphotropic virus type 1 (HTLV-1), a delta retrovirus family member, has been linked to multiple diseases. Here, we report that IFI16 expression is induced by HTLV-1 infection or HTLV-1 reverse transcription intermediate (RTI) ssDNA90 transfection. IFI16 overexpression decreases HTLV-1 protein expression, whereas IFI16 knockdown increases it. Furthermore, the knockdown of IFI16 is followed by impaired innate immune responses upon HTLV-1 infection. In addition, IFI16 forms a complex with ssDNA90 and enhances ssDNA90-triggered innate immune responses. Collectively, our data suggest a critical role for IFI16 during HTLV-1 infection by interacting with HTLV-1 RTI ssDNA90 and restricting HTLV-1 replication.
Interferon (IFN)-inducible protein 16 (IFI16) regulates human immunodeficiency virus replication by inducing innate immune responses as a DNA sensor. Human T-lymphotropic virus type 1 (HTLV-1), a delta retrovirus family member, has been linked to multiple diseases. Here, we report that IFI16 expression is induced by HTLV-1 infection or HTLV-1 reverse transcription intermediate (RTI) ssDNA90 transfection. IFI16 overexpression decreases HTLV-1 protein expression, whereas IFI16 knockdown increases it. Furthermore, the knockdown of IFI16 is followed by impaired innate immune responses upon HTLV-1 infection. In addition, IFI16 forms a complex with ssDNA90 and enhances ssDNA90-triggered innate immune responses. Collectively, our data suggest a critical role for IFI16 during HTLV-1 infection by interacting with HTLV-1 RTI ssDNA90 and restricting HTLV-1 replication.
Keywords: DNA sensor; HTLV-1; IFI16; innate immune responses; reverse transcription intermediate Interferon (IFN)-inducible protein 16 (IFI16) belongs to the PYHIN family, containing an N-terminal pyrin domain (PYD) and two C-terminal HIN domains, which are shared by most proteins in this family [1, 2] . The PYD domain is considered to be responsible for protein-protein interaction [3] . The HIN domain, having 200 amino acid residues (also called HIN-200 domain), harbors two consecutive oligosaccharide/oligonucleotide-binding folds (OB-folds), which can bind to DNA in a sequenceindependent manner [4] . In the primary studies, IFI16 was characterized as an IFN-inducible protein involved in DNA damage and cell cycle checkpoint [5] . Recent researches have indicated IFI16 as an important innate immune sensor which plays critical roles in antiviral innate immune responses [6] .
The function of IFI16 in antiviral immune responses as an intracellular DNA sensor was first demonstrated during herpes simplex virus (HSV)-1 infection [7] .
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Then, the critical role of IFI16 was identified in the antiviral immune responses against some other family members of Herpesviruses, all of which are DNA viruses, including human cytomegalovirus (HCMV), Kaposi's sarcoma-associated herpesvirus (KSHV), and Epstein-Barr virus [8] [9] [10] . In addition, it has been reported that IFI16 recognizes the DNA forms generated from replication of lentiviruses, induces the expression of IFNs, and regulates human immunodeficiency virus (HIV) replication in macrophages [11] . The mechanisms underlying the antiviral roles of IFI16 are complicated. It is accepted that IFI16 binds to viral DNA and forms a scaffold with it. The scaffold recruits stimulator of IFN genes (STING) and TANK-binding kinase 1 (TBK1), activates IFN regulatory factor (IRF) 3 and nuclear factor kappa-B (NF-jB), and finally induces the production of IFN-b [7, 12] . Some studies suggest that IFI16 could use other pathways to control viral replication, including the activation of apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC)-dependent inflammasome in response to KSHV infection, or recruitment of promyelocytic leukemia (PML) nuclear body components during HSV-1 infection [13, 14] . However, some results are controversial [15, 16] and whether these two pathways are involved in retrovirus-specific immune responses remains unknown. It is possible that the role of IFI16 in viral infection is celltype-dependent and virus-dependent. Therefore, it is of great importance to evaluate the role of IFI16 in host defense against other DNA viruses or retroviruses, especially the viruses that have been found to be related to human diseases.
Human T-lymphotropic virus type 1 (HTLV-1) was discovered as the first retrovirus associated with human diseases in 1980 [17] . It was estimated that HTLV-1 infected 10-20 million individuals worldwide [18] . The two major human diseases related to HTLV-1 infection are adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), neither of which can be effectively treated nowadays [19] [20] [21] . Although T cells are considered as the main target of HTLV, the virus could also infect innate immune cells, including monocytes, macrophages, and dendritic cells (DCs), all of which are critical in the host antiviral innate immune responses [22] . HTLV-1 is quite good at establishing a persistent infection and reaching equilibrium with host immune responses in vivo, usually with a high proviral load [23] . Less than 5% of the HTLV-1-infected individuals develop into ATL patients after a latency period of 20-30 years [24] . During such a long time, could the innate immune system recognize viral infection and fight against it? It has been demonstrated that the innate immune responses against HTLV-1 infection in killer plasmacytoid DCs (pDCs) is Toll-like receptor (TLR) 7-dependent [25] . The sensing of HTLV reverse transcription intermediate (RTI) ssDNA90 by STING triggers IRF3-dependent antiviral and apoptotic responses in monocytes, leading to abortive infection in these cells [26] . Recently, the role of IFI16 in HIV replication provided new clue to explore key regulators which might be involved in the host innate immune responses against HTLV-1 invasion.
Here, we show that IFI16, which could be induced by HTLV-1 infection, interacted with HTLV-1 RTI ssDNA90. IFI16 promoted innate immune responses, including the production of IFN-b, IFN responsive genes, and proinflammatory cytokines, leading to the inhibition of HTLV-1 protein expression. Our results suggest that IFI16 limited HTLV-1 replication by enhancing HTLV-1 RTI-triggered innate immune responses. This research may help us to understand the role of DNA sensors in HTLV-1 infection more deeply.
Materials and methods

Plasmid constructs and reagents
Human IFI16 and absent in melanoma 2 (AIM2) were amplified by PCR using cDNA from MT2 cocultured PMA-differentiated THP1 cells (PMA-THP1). The PCR products were subsequently cloned into a pcDNA3-hemagglutinin (HA) vector (Invitrogen, Waltham, MA, USA). Flag-STING, the 90-base-long HTLV-1 ssDNA90, and scrambled ssDNA90 were obtained as described previously [27] . Cell culture and transfection 
Cell-free HTLV-1 infection
The supernatants of overnight seeded MT2 cells were collected and ultracentrifuged for 2 h at 30 000 g at 4°C. The viral pellet was resuspended in RPMI 1640, and HTLV-1 particles were quantified by gag p19 ELISA assays (ZeptoMetrix, Buffalo, NY, USA). A total of 250 000 purified macrophages were incubated with 2 lg HTLV-1 for 24 h in RPMI 1640.
Immunoprecipitation and immunoblot analysis
Immunoprecipitation and immunoblot analyses were performed as described previously [27] . In short, cells were transfected with various combinations of plasmids or siRNA. At 24 h after the transfection, the cell lysates were prepared in lysis buffer containing 1.0% (vol/vol) Nonidet P40, 20 mM Tris-HCl, pH 8.0, 10% (vol/vol) glycerol, 150 mM NaCl, 0.2 mM Na 3 VO 4 , 1 mM NaF, 0.1 mM sodium pyrophosphate, and protease inhibitor cocktail (Roche, Basel, Switzerland). After centrifugation for 20 min at 14 000 g, supernatants were collected and incubated with the indicated antibody together with protein A/G Plus-agarose immunoprecipitation reagent (Santa Cruz Biotechnology) at 4°C for 3 h or overnight. After three washes, the immunoprecipitants were boiled in SDS sample buffer for 10 min and analyzed by immunoblot.
Real-time PCR
Total RNA was extracted from the cultured cells with TRIzol reagent (Invitrogen) as described by the manufacturer and reverse transcribed using MMLV reverse transcriptase (Invitrogen). All gene transcripts were quantified by realtime PCR with SYBR Green qPCR Master Mix using a 7500 Fast real-time PCR system (Applied Biosystems, Foster City, CA, USA). The relative fold induction was calculated using the 2 ÀMMCt method. Template cDNA loading was normalized by the average expression of GAPDH. The primers used for real-time PCR were as follows: Tax C-X-C motif chemokine 10 (CXCL10), Forward, 5
RNA interference IFI16-Stealth-RNA interference was designed by the Invitrogen BLOCKiT RNAi Designer. The small interfering RNA (siRNA) sequences used were as follows:
STING-Stealth-RNA interference and the cGAS-Stealth-RNA interference were obtained as described previously [28] .
The negative control siRNA (SC) was purchased from Invitrogen (catalog no.12935300).
THP1, HeLa, or human monocytes were transfected with siRNA using Lipofectamine 2000 according to the manufacturer's instructions. At 24 h after transfection, the cells were used for further experiments.
Confocal microscopy
After indicated transfection, HeLa cells were fixed with 4% PFA in PBS, permeabilized with Triton X-100, and blocked with 1% BSA in PBS. Nuclei were stained with 4, 6-diamidino-2-phenylindole (DAPI).
Nuclear extracts
Nuclear extracts were prepared as described previously [29] . Briefly, cells were harvested and washed with PBS. Cells were lysed with buffer A (10 mM HEPES, 1.5 mM MgCl 2 Á6 H 2 O, 10 mM KCl, 0.5 mM DTT, protease inhibitor cocktail, 0.1% Nonidet P-40, pH7.9). Lysate was placed on ice for 10 min and centrifuged at 12 000 g for 5 min at 4°C to remove cytoplasmic proteins. Nuclear proteins were extracted from the pellet in ice-cold buffer C (20 mM HEPES, 1.5 mM MgCl 2 Á6 H 2 O, 0.42 M NaCl, 0.2 mM EDTA, 25% glycerol, 0.5 mM DTT, protease inhibitor cocktail, pH7.9). Insoluble material was removed by centrifugation at 10 000 r.p.m. for 5 min at 4°C. Protein concentration was measured with the BCA protein assay reagent kit according to the manufacturer's instructions.
Statistics
The data are presented as the means AE SD from at least three independent experiments. The statistical comparisons between the different treatments were performed using the Mann-Whitney test, and P < 0.05 was considered statistically significant.
Results
IFI16 expression is induced by HTLV-1 infection
It has been reported that IFI16 expression could be induced by VACV DNA motif [7] . We wondered whether HTLV-1 infection or its RTI ssDNA90 was able to trigger IFI16 induction. HeLa or PMA-differentiated THP1 (a human macrophage-like cell line, PMA-THP1) cells were cocultured with MT2 (HTLV-1-transformed T-cell line) cells or transfected with ssDNA90 and the IFI16 expression was analyzed by immunoblot. As shown in Fig. 1A ,B, after MT2 coculture or ssDNA90 transfection, both HeLa and PMA-THP1 cells displayed higher expression levels of IFI16. MT4 cells, another HTLV-1-transformed T-cell line, were used to repeat the experiment and elevated IFI16 expression was observed in MT4-cocultured PMA-THP1 cells (Fig. 1C) . Next, we confirmed these results in primary human monocytes. Consistently, increased expression of IFI16 protein was observed in MT2-cocultured primary human monocytes (Fig. 1D) . Jones et al. [30] reported that DC could be infected by cell-free HTLV virions. Thus, we tried to investigate the effect of cell-free HTLV-1 infection on IFI16 expression. Immunoblot assays showed that IFI16 expression was markedly upregulated in human monocyte-derived macrophage (hMDMs) after cell-free HTLV-1 infection (Fig. 1E) . Collectively, these observations indicated that IFI16 was inducible by HTLV-1 infection or HTLV-1 RTI ssDNA90 transfection.
IFI16 regulates HTLV-1 protein expression
Since IFI16 could be induced by HTLV-1 infection, we examined the effects of IFI16 on HTLV-1 replication. Empty vector, IFI16 or its family member, AIM2 was transfected into PMA-THP1 cells separately. Then, the cells were cocultured with MT2 cells and the mRNA levels of HTLV-1 proteins were examined by real-time PCR assays. As shown in Fig. 2A , the expression levels of HTLV-1 protein Tax and p19 were decreased in the presence of IFI16, but not in the presence of AIM2, suggesting that IFI16 might negatively regulate HTLV-1 replication. Similar results were observed in HeLa cells (Fig. S1A,B) . We further investigated the effects of endogenous IFI16 on HTLV-1 replication using the knockdown approach. We purchased three pairs of siRNA oligonucleotides specific for IFI16 RNA (F1, F2, and F3), with a paired SC and examined their effects on IFI16 expression by immunoblot assays. The results suggested that F3 most efficiently inhibited exogenous IFI16 expression in HEK293T cells (Fig. 2B ) and F3 could also silence endogenous IFI16 expression in MT2-cocultured PMA-THP1 cells (Fig. 2C) . Thus, F3 was used to examine the role of endogenous IFI16 during HTLV-1 infection. In real-time PCR assays, the knockdown of endogenous IFI16 increased the HTLV-1 protein expression in mRNA levels after MT2 or MT4 coculture ( Figs 2D and S1C) . Similar results were observed in HeLa cells (Fig. S1D) . Consistently, immunoblot assays demonstrated higher protein levels of HTLV-1 protein Tax and p19 after the knockdown of IFI16 in PMA-THP1 cells (Fig. 2E) . Moreover, we investigated the role of IFI16 as a negative regulator of HTLV-1 replication in primary human innate immune cells and similar results were obtained in primary human monocytes (Fig. 2F,G) . In addition, stable IFI16-knockdown PMA-THP1 cells were generated by lentivirus transduction, in which enhanced expression of HTLV-1 proteins in both mRNA and protein levels were observed (Fig. S1E,F) . Taken together, these data indicated IFI16 negatively regulated HTLV-1 protein expression.
IFI16 increases HTLV-1-induced innate immune responses
We next sought to determine the mechanism by which IFI16-regulated HTLV-1 replication. Innate immunity is considered as the first line of host defense against viral infection. It has been reported that IFI16 is The data are representative of three independent experiments and are presented as means AE SD (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001. required for DNA-or HSV-1-induced innate immune responses, including the production of IFN-b, TNF-a, CCL5, and CXCL10 [7] . Therefore, we first tested the effects of IFI16 on host antiviral innate immune responses. PMA-THP1 cells were transfected with SC or F3 and then cocultured with MT2 cells. At 24 h after coculture, the cells were subjected to real-time PCR assays to examine the induction of cytokines. As shown in Fig. 3A , the production of IFN-b, TNF-a, CCL5, and CXCL10 could be induced by HTLV-1 infection and impaired by IFI16 knockdown in PMA-THP1 cells. Similar results were obtained from the primary human monocytes (Fig. 3B ). In addition, the knockdown of IFI16 caused decreased phosphorylation of IRF3 and p65 in both PMA-THP1 cells and primary human monocytes after coculture with MT2 cells (Fig. 3C,D) . Consistently, real-time PCR and immunoblot assays demonstrated impaired antiviral innate immune responses in IFI16-silenced PMA-THP1 cells after MT4-coculture (Fig. S2A,B) . Furthermore, stable IFI16-knockdown PMA-THP1 cells displayed impaired production of IFN-b and TNF-a upon HTLV-1 infection (Fig. S2C) . Thus, these results indicated that IFI16 was a positive regulator of HTLV-1-induced innate immune responses.
IFI16 interacts with HTLV-1 RTI ssDNA90
As IFI16 is a known DNA sensor, we tried to determine whether IFI16 could recognize and form a complex with HTLV-1 RTI. ssDNA90 with or without biotinylation was transfected into HeLa cells together with HA-IFI16 and coimmunoprecipitation experiments were performed. As shown in Fig. 4A , the results indicated that IFI16 interacted with ssDNA90. Furthermore, competition experiment suggested that the association of Biotin-ssDNA90 with IFI16 could be competed by ssDNA90 in a dose-dependent manner, but not by an irrelevant ssDNA (scrambled ssDNA90; Fig. 4B ). Moreover, the interaction between endogenous IFI16 and transfected ssDNA90 was detected in HeLa cells (Fig. 4C ). In conclusion, our results suggested IFI16 recognized and formed a complex with HTLV-1 RTI ssDNA90.
IFI16 increases ssDNA90-induced innate immune responses
Because of the interaction of IFI16 with ssDNA90, we investigated the effects of IFI16 on ssDNA90-induced innate immune responses. The real-time PCR assays revealed that the induction of IFN-b and TNF-a by ssDNA90 transfection was enhanced in the IFI16-overexpressing HeLa cells (Fig. S3A ). In agreement with this observation, ssDNA90-induced activation of IRF3 and p65 was increased in IFI16-overexpressing HeLa cells as suggested by the phosphorylation levels of these transcription factors (Fig. S3B) . Consistently, . At 24 h after transfection, the cells were transfected with 0.5 lgÁmL À1 ssDNA90 for another 8 h. Then, the cells were lysed for immunoblot assays. b-actin was used as a loading control in the immunoblot assays. The data are representative of three independent experiments and are presented as means AE SD (n = 3). **P < 0.01, ***P < 0.001.
the induction of IFN-b and TNF-a by ssDNA90 transfection was impaired in both PMA-THP1 cells and human monocytes after IFI16 knockdown (Fig. 4D,E) . Similar results were observed in HeLa cells (Fig. S3C) . In addition, ssDNA90-induced activation of IRF3 and p65 was inhibited in IFI16-silenced PMA-THP1 cells and primary human monocytes (Fig. 4F,G) . Furthermore, stable IFI16-knockdown PMA-THP1 cells displayed decreased innate immune responses upon ssDNA90 transfection (Fig. S3D,E) . Together, our findings suggested that IFI16 was required by ssDNA90-induced innate immune responses.
STING is critical to IFI16-induced innate immune responses upon HTLV-1 infection
IFI16 was reported to induce IFN-b production through STING recruitment [7] . Therefore, we investigated the role of STING in IFI16-induced innate immune responses upon HTLV-1 infection. HA-IFI16 and Flag-STING were transfected into HeLa cells and coimmunoprecipitation assays were performed. As shown in Fig. 5A , IFI16 interacted with STING with or without HTLV-1 infection. Next, we addressed whether this interaction occurred under physiological conditions. We detected endogenous association between IFI16 and STING. As shown in Fig. 5B , in PMA-THP1 cells, the expression level of IFI16 was very low and no significant interaction between IFI16 and STING was detected. However, after HTLV-1 infection, we observed a strong interaction between endogenous IFI16 and STING (Fig. 5B ). This phenomenon was confirmed by confocal microscopy experiments. Without stimulation, IFI16 located in the nucleus of HeLa cells whereas STING located in the cytoplasm (Fig. 5C ). After ssDNA90 transfection, the expression of IFI16 was enhanced and part of IFI16 protein translocated from the nucleus to the cytoplasm where it colocalized with STING ( Fig. 5C ). Furthermore, coimmunoprecipitation experiments indicated that the interaction between IFI16 and STING was only observed in the cytoplasmic extracts but not in the nuclear extracts (Fig. 5D ). Next, we assessed whether STING was involved in IFI16-mediated host defense against HTLV-1. As shown in Fig. 5E , after the knockdown of STING, the expression levels of HTLV-1 protein Tax and p19 were elevated. In addition, in STING-silenced HeLa cells, exogenous expression of IFI16 had only slight effect on Tax and p19 expression, suggesting the critical role of STING in the function of IFI16 during HTLV-1 infection (Fig. 5E ). It has been reported that another important DNA sensor, cGAS, could stabilize IFI16 and enhance the innate immune responses against HSV infection [31] . Thus, we further studied the effect of cGAS on IFI16-induced innate immune responses upon HTLV-1 infection. As shown in Fig. 5F , the cGAS-silenced HeLa cells displayed a higher expression level of p19, suggesting cGAS played a role in HTLV-1 infection. However, after cGAS knockdown, IFI16 still had a significant effect on p19 expression (Fig. 5F ). In addition, in cGAS-silenced PMA-THP1 cells, IFI16-knockdown still had a significant effect on p19 expression, the phosphorylation of IRF3, and the production of IFN-b, suggesting the function of IFI16 in innate immunity during HTLV-1 infection might be cGASindependent (Figs 5G and S4). Taken together, these findings suggested that IFI16-induced host antiviral immune responses against HTLV-1 infection in a STING-dependent way.
Discussion
Although HTLV-1 preferentially integrates into the genome of CD4+ T cells and the adaptive immune responses are critical to HTLV-1 pathophysiology, clinical treatment targeting the adaptive immune response has slight effects on disease progression [32, 33] . It is noteworthy that HTLV-1 also infects innate immune cells in vitro and in vivo [22] , which are usually considered as the first line of host defense against viral invasion. Treatment that is designed to regulate host innate immune responses might be a potential therapeutic strategy to limit clinical symptoms. However, the design of this strategy is dependent on profound understanding of the host-virus interaction. Novel molecules and pathways regulating HTLV-1 replication need to be identified as potential targets for clinical treatment. One critical step in HTLV-1 replication is the reverse transcription of viral RNA to produce ssDNA intermediates. The HTLV-1 RTIs play an important role in antiviral response and HTLV-1 infection. The RTIs, generated in the presence of SAMHD1, could be sensed by STING [26] . The RTIs-STING complex initiates antiviral and apoptotic responses, leading to abortive infection in monocytes [26] . Although the apoptotic responses differ in other cell contexts, the accumulated RTIs provide the possibility that DNA sensors may detect HTLV-1 and triggers antiviral responses. Our findings showed that IFI16 was inducible in different kinds of cells, including HeLa cells, the macrophage-like PMA-THP1 cells, primary human monocytes, and primary human macrophages, by MT2-coculture or cell-free HTLV-1 virions infection. It has been reported that IFI16 associates with ssDNA derived from HIV-1 proviral DNA, stimulates both type I IFN and proinflammatory responses, and limits HIV replication [11] . Thus, it was reasonable for us to propose the hypothesis that IFI16 might play a role during HTLV-1 infection.
To test this hypothesis, we investigated the role of IFI16 in HTLV-1 infection by upregulating or downregulating its expression. We observed that IFI16 overexpression negatively regulated the expression of HTLV-1 protein Tax and p19 in MT2-cocultured HeLa and PMA-THP1 cells. Interestingly, AIM2, the family member of IFI16, which is considered as a dsDNA sensor and initiates inflammatory responses to dsDNA but not ssDNA or RNA [34] , had no significant effect on HTLV-1 protein expression. To explore the effects of endogenous IFI16 on HTLV-1 replication, we downregulated the expression of IFI16 by siRNA or shRNA and enhanced HTLV-1 protein expression levels were observed.
To investigate the mechanism by which IFI16-modulated HTLV-1 infection, we examined the effects of IFI16 on the antiviral innate immune responses against HTLV-1 infection. Our findings indicated that IFI16 increased the activation of IRF3 and NF-jB, leading to elevated expression levels of IFN-b, IFNresponsive proteins and proinflammatory cytokines in HTLV-1-infected HeLa, PMA-THP1 cells, and primary human monocytes, suggesting a critical role of IFI16 in HTLV-1-induced innate immune responses. Then, could IFI16 function as a DNA sensor during HTLV-1 infection? Our findings revealed that IFI16 was associated with HTLV-1 RTI ssDNA90. We further explored the effects of IFI16 on ssDNA90-induced signaling pathways and found that IFI16 increased the phosphorylation levels of IRF3 and NFjB and the induction of IFN-b and TNF-a after ssDNA90 transfection. Thus, we suggested that IFI16 regulated HTLV-1 replication during HTLV-1 infection as a DNA sensor.
STING has been characterized as the key adaptor in IFI16-mediated signaling pathways during HSV-1 infection [7] . Orzalli et al. has reported that cGAS cooperates with IFI16 and enhances the stability of IFI16 during HSV infection [31] . These studies provided clues for us to identify the molecules critical to IFI16-induced antiviral responses against HTLV-1 infection. After STING knockdown, the expression levels of HTLV-1 protein were higher and were not affected by IFI16 overexpression, indicating the important role of STING in IFI16-mediated signaling pathways during HTLV-1 infection. However, although cGAS knockdown resulted in elevated HTLV-1 protein expression, IFI16 still had effects on HTLV-1 protein expression in cGAS-silenced cells, suggesting cGAS might not be involved in IFI16-mediated signaling pathways during HTLV-1 infection.
Our results indicated that after ssDNA90 stimulation, IFI16 translocated from the nucleus to the cytoplasm where it colocalized with STING, leading to downstream signal transduction. Although it has been reported that acetylation could modulate the cellular distribution of IFI16 [35] , it remains unclear by which mechanism the ssDNA90 binding induces this translocation. In addition, our previous research suggested that another DNA sensor, Ku70, also played a role in regulating HTLV-1 replication [28] . How could these different types of DNA sensors, including STING, IFI16, Ku70, and cGAS, team up to fight against HTLV-1 infection? Further researches about the interaction between protective antiviral responses and HTLV-1 infection are needed.
Collectively, our data suggested a critical role for the DNA sensor IFI16 in HTLV-1 infection. IFI16 recognized HTLV-1 RTI ssDNA90, interacted with STING, enhanced antiviral responses, and restricted HTLV-1 replication. These findings may contribute to our understanding of the basic pathobiology of HTLV-1 and provide new molecules as targets for clinical treatment.
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